Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

Human Gene Therapy

Volumn 12, Issue 18, 2001, Pages 2203-2213

  Metharom, Pat ^a,c   Ellem, Kay A O ^b   Schmidt, Chris ^b   Wei, Ming Q ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; MELANOMA ANTIGEN; TUMOR REJECTION ANTIGEN; TYROSINASE RELATED PROTEIN 2; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CODING; CONTROLLED STUDY; DENDRITIC CELL; DISEASE CLASSIFICATION; FEMALE; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MELANOMA; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROVOCATION TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VACCINATION;

ANIMALS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HIV-1; HUMANS; IMMUNOTHERAPY; INTRAMOLECULAR OXIDOREDUCTASES; MELANOMA; MICE; MICE, INBRED C57BL;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE;

EID: 0035695838     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340152710540     Document Type: Article

References (45)

1. Lentiviral vectors - The promise of gene therapy within reach?
2. A comparison of gene transfer methods in human dendritic cells
3. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression
4. +cord blood cells under serum-free conditions
5. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
6. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
7. Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
8. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
9. Prolonged survival in metastatic malignant melanoma associated with vitiligo
10. The labyrinthine ways of cancer immunotherapy - T cell, tumor cell encounter: "How do I lose thee? Let me count the ways.
11. Retroviral gene transfer, rapid selection, and maintenance of the immature phenotype in mouse dendritic cells
12. Melanoma-associated tumor antigens and their clinical relevance to immunotherapy
13. Lymphokine-activated killer cell phenomenon: Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
14. Dendritic cells: Unique leukocyte populations which control the primary immune response
15. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors
16. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
17. The central role of CD4+ T cells in antitumor immune response
18. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
19. Functional analysis of the slaty gene product (TRP-2) as dopachrome tautomerase and the effect of a point mutation on its catalytic function
20. Transduction of CD34+ cells by a vesicular stomatitis virus protein G (VSV-G) pseudotyped HIV-1 vector: Stable gene expression in progeny cells, including dendritic cells
21. CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes
22. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
23. Mutational analysis of the modulation of tyrosinase by tyrosinase-related proteins 1 and 2in vitro
24. Novel bovine lentiviral vectors based on Jembrana disease virus
25. +cells
26. Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates
27. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture
28. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
29. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression
30. Comparative decreases in tyrosinase, TRP-1, TRP-2 and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanoma and metastases
31. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene
32. The dendritic cell system and its role in immunogenicity
33. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets
34. Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters
35. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen
36. A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer
37. Induced expression of B7.1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells
38. The presence of tyrosinase and related proteins in human epidermis and their relationship to melanin type
39. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed dopachrome tautomerase
40. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity
41. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
42. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
43. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
44. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
45. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin